Yahoo Finance

Cone Rod Dystrophy Market Research Report 2025-2035: Gene Editing and Collaborations Drive Innovations

Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "Cone Rod Dystrophy Market - A Global and Regional Analysis: Focus on Regional and Country Analysis - Analysis and Forecast, 2025-2035" report has been ...
Yahoo Finance

Cone Rod Dystrophy Market Report 2025-2030, with Profiles of SparingVision, Beacon Therapeutics, Nanoscope Therapeutics, MeiraGTx, Ascidian Therapeutics, jCyte, BlueRock ...

Dublin, April 29, 2025 (GLOBE NEWSWIRE) -- The "Cone Rod Dystrophy Market: Analysis By Type, By Treatment Type, By End User, By Region Size and Trends - Forecast up to 2030" has been added to ...
Healio

Girl presents with lifelong history of poor vision in both eyes

A 15-year-old girl presented to the eye clinic at the New England Eye Center for a second opinion regarding reduced vision in both eyes since infancy. She was born at 36 weeks’ gestation with an ...
Medscape

The Genetics of Hereditary Retinopathies and Optic Neuropathies

For mere clinical classification purposes, rod-cone dystrophies can be broadly divided into early onset forms (i.e., which are either consistently severe from birth with little progression thereafter ...
Business Wire

OcuSciences Announces Publication of Study Showing Novel Flavoprotein Fluorescence Measure Is Increased in Inherited Retinal Dystrophies

ANN ARBOR, Mich.--(BUSINESS WIRE)--OcuSciences, Inc., a medical device company developing retinal imagers to detect early disease by assessing retinal metabolic activity, today announced the ...
Business Wire

VARIANT Receives European Orphan Drug Designation for its Gene Therapy Product Candidate, VAR002, for the Treatment of Both Leber Congenital Amaurosis and Cone-Rod dystrophy

PARIS--(BUSINESS WIRE)--Variant, a company dedicated to developing innovative treatments for inherited eye orphan diseases, announces the decision of the European Commission to grant Orphan Drug ...